Loading...
Experimental platform demonstrates tunable mid-infrared detection of protein monolayers using graphene plasmonics, suggesting advanced label-free biosensing capabilities.
A 2015 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: